Mettler-Toledo International (NYSE:MTD) Price Target Cut to $1,125.00 by Analysts at Wells Fargo & Company

Mettler-Toledo International (NYSE:MTD) had its price target reduced by Wells Fargo & Company from $1,400.00 to $1,125.00 in a research report sent to investors on Thursday,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the medical instruments supplier’s stock.

MTD has been the topic of several other reports. Evercore ISI lifted their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a report on Monday, February 10th. Citigroup raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price objective on the stock in a report on Monday, April 7th. Finally, Robert W. Baird boosted their price target on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. One analyst has rated the stock with a sell rating, five have given a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and an average target price of $1,346.13.

Mettler-Toledo International Price Performance

MTD stock opened at $1,004.72 on Thursday. Mettler-Toledo International has a 1-year low of $946.69 and a 1-year high of $1,546.93. The business has a 50 day simple moving average of $1,191.96 and a two-hundred day simple moving average of $1,264.86. The company has a market capitalization of $20.94 billion, a price-to-earnings ratio of 24.79, a PEG ratio of 3.30 and a beta of 1.28.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. Sell-side analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the transaction, the insider now owns 6 shares in the company, valued at $8,108.04. The trade was a 99.01 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Christian Magloth sold 790 shares of the stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares in the company, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. JPMorgan Chase & Co. boosted its position in Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after buying an additional 28,478 shares during the period. M&T Bank Corp raised its stake in shares of Mettler-Toledo International by 14.3% during the third quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock valued at $7,387,000 after acquiring an additional 615 shares in the last quarter. Allworth Financial LP boosted its holdings in shares of Mettler-Toledo International by 367.4% in the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier’s stock valued at $285,000 after purchasing an additional 169 shares during the period. Nordea Investment Management AB boosted its holdings in shares of Mettler-Toledo International by 29.8% in the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier’s stock valued at $129,919,000 after purchasing an additional 24,285 shares during the period. Finally, Robeco Institutional Asset Management B.V. grew its stake in Mettler-Toledo International by 18.0% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier’s stock worth $42,058,000 after purchasing an additional 5,234 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.